Drugs / DWP708
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05378360 | May 2022 → Dec 2023 | acneiform dermatitis | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWP708 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05378360 ↗ |
| Route | Topical | “EGF Cream 10 ug/g evenly apply to skin lesion every 12 hr/day” NCT05378360 ↗ |